Therefore, it is necessary to explore whether the AGs influences the treatment of cancer with R213X mutation, to explore whether full-length p53 proteins induced by GK-Ae produce normal function, and to explore safety issues related to nephrotoxicity and ototoxicity. The gene discussed is TP53; the disease is cancer.